Among the six investigated genes, our study revealed significant results for TGFβ-1 and CXCR4. Therefore, targeting TGFβ-1 and CXCR4 with the potential drug inhibitors may prove a significant approach to target breast cancer. This evidence concerns the gene CXCR4 and breast cancer.